These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 27612888)

  • 21. Relationship of HDL-C and Triglyceride with Type 2 Diabetes Mellitus in Adult Female.
    Salma MU; Nessa A; Saki SA
    Mymensingh Med J; 2019 Apr; 28(2):306-310. PubMed ID: 31086143
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lipid profile abnormalities seen in T2DM patients in primary healthcare in Turkey: a cross-sectional study.
    Ozder A
    Lipids Health Dis; 2014 Dec; 13():183. PubMed ID: 25481115
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The pattern of dyslipidemia among urban African-Americans with type 2 diabetes.
    Cook CB; Erdman DM; Ryan GJ; Greenlund KJ; Giles WH; Gallina DL; El-Kebbi IM; Ziemer DC; Ernst KL; Dunbar VG; Phillips LS
    Diabetes Care; 2000 Mar; 23(3):319-24. PubMed ID: 10868858
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lipoprotein abnormalities and their consequences for patients with type 2 diabetes.
    Krentz AJ
    Diabetes Obes Metab; 2003 Nov; 5 Suppl 1():S19-27. PubMed ID: 14984018
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of glycaemic control on the prevalence and pattern of dyslipidaemia in Nigerian patients with newly diagnosed non insulin dependent diabetes mellitus.
    Agboola-Abu CF; Ohwovoriole AE; Akinlade KS
    West Afr J Med; 2000; 19(1):27-33. PubMed ID: 10821083
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of dyslipidemia and factors affecting lipid profile in patients with type 2 diabetes.
    Shahwan MJ; Jairoun AA; Farajallah A; Shanabli S
    Diabetes Metab Syndr; 2019; 13(4):2387-2392. PubMed ID: 31405648
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of antioxidant status of female diabetic patients in Nnamdi Azikiwe University Teaching Hospital, Anambra State, Nigeria.
    Okuonghae EO; Onyenekwe CC; Ahaneku JE; Ukibe NR; Nwani PO; Asomugha AL; Osakue NO; Aidomeh F; Awalu CC
    Br J Biomed Sci; 2015; 72(4):164-7. PubMed ID: 26738397
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence and phenotypic distribution of dyslipidemia in type 1 diabetes mellitus: effect of glycemic control.
    Pérez A; Wägner AM; Carreras G; Giménez G; Sánchez-Quesada JL; Rigla M; Gómez-Gerique JA; Pou JM; de Leiva A
    Arch Intern Med; 2000 Oct; 160(18):2756-62. PubMed ID: 11025785
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Atorvastatin for the management of Type 2 diabetic patients with dyslipidaemia. A mid-term (9 months) treatment experience.
    Velussi M; Cernigoi AM; Tortul C; Merni M
    Diabetes Nutr Metab; 1999 Dec; 12(6):407-12. PubMed ID: 10782562
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of Vitamin D Deficiency, Dyslipidemia, and Obesity with the Incidence of Coronary Artery Diseases in Type 2 Diabetic Saudi Patients.
    Gharib AF; Askary AE; Almehmadi M; Allam HH; Elsayyad LK; Althobaiti BB; Almoudhi EA; Alwethenany SH; Zahrani RAA; Shafie A
    Clin Lab; 2022 Oct; 68(10):. PubMed ID: 36250846
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Differences in glycemic balance (but not weight) correlate positively with changes in absolute cardiovascular risk in diabetic patients].
    Hadjadj S; Guilloteau G; Weekers L; Bouhanick B; Fressinaud P; Marre M
    Arch Mal Coeur Vaiss; 2000 Aug; 93(8):1033-6. PubMed ID: 10989752
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Longitudinal trends in lipid profile in indian children and youth with type-1 diabetes: a 5-year follow up from a single centre.
    Oza C; Khadilkar A; Mondkar SA; Gondhalekar K; Khadilkar V
    Endocrine; 2023 Feb; 79(2):313-322. PubMed ID: 36414859
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The importance of serum lipids in exudative diabetic macular edema in type 2 diabetic patients.
    Uçgun NI; Yildirim Z; Kiliç N; Gürsel E
    Ann N Y Acad Sci; 2007 Apr; 1100():213-7. PubMed ID: 17460181
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence and Determinants of Occurrence of Dyslipidemia in Subjects with Type 1 Diabetes Mellitus.
    Selvaraj M; Prasad HK; White S; Prasanna B; Sangaralingam T
    Indian J Pediatr; 2023 Feb; 90(2):118-123. PubMed ID: 35366198
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Study of Body Mass Index, Fasting Serum Glucose and Glycated Hemoglobin in Type 2 Diabetic Female Patients.
    Lucky DA; Nessa A; Sharmin A; Farid GF; Yesmin S
    Mymensingh Med J; 2024 Jan; 33(1):97-100. PubMed ID: 38163779
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Classical cardiovascular risk factors in Trinidadian patients with type 2 diabetes mellitus are not influenced by the level of plasma glycaemia.
    Ezenwaka CE; Offiah NV
    West Indian Med J; 2001 Dec; 50(4):288-93. PubMed ID: 11993019
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The relationship between nonfasting and fasting lipid measurements in patients with or without type 2 diabetes mellitus receiving treatment with 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors.
    Weiss R; Harder M; Rowe J
    Clin Ther; 2003 May; 25(5):1490-7. PubMed ID: 12867223
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peroxisome proliferator-activated receptor-gamma agonist increases both low-density lipoprotein cholesterol particle size and small high-density lipoprotein cholesterol in patients with type 2 diabetes independent of diabetic control.
    Bavirti S; Ghanaat F; Tayek JA
    Endocr Pract; 2003; 9(6):487-93. PubMed ID: 14715475
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect Of Sitagliptin On Glycemic Control, Body Weight, Blood Pressure And Serum Lipid Profile In Type 2 Diabetic Hyperlipidemic Patients.
    Hussain M; Atif MA; Tunio AG; Ali B; Akhtar L; Serwar G
    J Ayub Med Coll Abbottabad; 2016; 28(2):369-372. PubMed ID: 28718546
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lipid-lowering effect of simvastatin in patients of type 2 diabetes mellitus.
    Udawat H; Goyal RK
    Indian Heart J; 2001; 53(2):172-6. PubMed ID: 11428472
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.